Chronic rhinosinusitis effects n estimated 15% of the population of the United States, and the prevalence of this disease has been rising over the past decade. Annual direct medical costs are conservatively estimated at $2.4 billion; excluding the costs associated with the almost 200,000 sinus surgeries performed each year. Despite the high incidence of chronic rhinosinusitis, and its major impact on the health care system, little is known regarding the etiology and pathogenesis of this disease. Epithelial hyperplasia and inflammation are consistent and striking features of chronic rhinosinusitis. Indeed, imaging of these mucosal changes by CT or MRI is used to support diagnosis. It remains our central hypothesis that epithelial cell/mucosal dysfunction plays a central role in the pathogenesis of chronic rhinosinusitis. This dysfunction may arise due to an inherent genetic defect(s) environmental influences, or, most likely, a combination of the two. This Program Grant presents an integrated, multi-disciplinary approach to test this central hypothesis. The first project continues to focus on the potential genetic predisposition of some subjects to develop chronic rhinosinusitis. Specifically, a variety of approaches will be used to further test the hypothesis that patients with chronic rhinosinusitis have a higher rte of mutations in the cystic fibrosis transmembrane regulator than the health population. The second project focuses on the role of a specific environmental factor, respiratory viral infection as a trigger factor in altering epithelial cell function in a manner that plays a role in the pathogenesis of chronic rhinosinusitis. The third project has demonstrated that patients with refractory chronic rhinosinusitis demonstrated mucosal hyporesponsiveness to stimuli such as histamine, despite the presence of profound inflammation. Efforts will focus on determining the mechanism underlying this hyporesponsiveness and on evaluating if there is a familial predisposition for mucosal hyporesponsiveness. The three projects will interact by sharing protocols, expertise and patients, as well as through intellectual exchange. All three projects depend absolutely on the CORE for recruitment and characterization of patients and control population, and for critical support services. These studies should include important insights into the pathogenesis of chronic rhinosinusitis and may lead to the development of new approaches for the treatment of this major health problem.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI037163-07
Application #
6373438
Study Section
Special Emphasis Panel (ZAI1-MSQ-I (S4))
Program Officer
Plaut, Marshall
Project Start
1995-09-30
Project End
2003-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
7
Fiscal Year
2001
Total Cost
$877,881
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Cruz, Alvaro A; Naclerio, Robert M; Proud, David et al. (2006) Epithelial shedding is associated with nasal reactions to cold, dry air. J Allergy Clin Immunol 117:1351-8
Sanders, Scherer P; Proud, David; Permutt, Solbert et al. (2004) Role of nasal nitric oxide in the resolution of experimental rhinovirus infection. J Allergy Clin Immunol 113:697-702
Subauste, M C; Proud, D (2001) Effects of tumor necrosis factor-alpha, epidermal growth factor and transforming growth factor-alpha on interleukin-8 production by, and human rhinovirus replication in, bronchial epithelial cells. Int Immunopharmacol 1:1229-34
Sanders, S P; Kim, J; Connolly, K R et al. (2001) Nitric oxide inhibits rhinovirus-induced granulocyte macrophage colony-stimulating factor production in bronchial epithelial cells. Am J Respir Cell Mol Biol 24:317-25
Sanders, S P; Siekierski, E S; Richards, S M et al. (2001) Rhinovirus infection induces expression of type 2 nitric oxide synthase in human respiratory epithelial cells in vitro and in vivo. J Allergy Clin Immunol 107:235-43
Kim, J; Sanders, S P; Siekierski, E S et al. (2000) Role of NF-kappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol 165:3384-92
Kidney, J C; Proud, D (2000) Neutrophil transmigration across human airway epithelial monolayers: mechanisms and dependence on electrical resistance. Am J Respir Cell Mol Biol 23:389-95
Togias, A (1999) Mechanisms of nose-lung interaction. Allergy 54 Suppl 57:94-105
Rhyoo, C; Sanders, S P; Leopold, D A et al. (1999) Sinus mucosal IL-8 gene expression in chronic rhinosinusitis. J Allergy Clin Immunol 103:395-400
Sanders, S P; Siekierski, E S; Porter, J D et al. (1998) Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 72:934-42

Showing the most recent 10 out of 12 publications